IL15 and hepatocellular carcinoma: engineered fourth generation CAR-T directed against GPC3+ composed of a 4-1BB costimulatory motif and co-expressing both IL-21 and IL-15 and found superior expansion and antitumor activity against HCC in a preclinical model.